Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Aichi, Japan.
Department of Gastroenterology and Hepatology, Fujita Health University School of Medicine, 1-98 Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Ir J Med Sci. 2024 Feb;193(1):173-179. doi: 10.1007/s11845-023-03450-2. Epub 2023 Jul 11.
Rebleeding after hemostasis of the gastroduodenal ulcer (GDU) is one of the indicators associated with death among GDU patients. However, there are few studies on risk score that contribute to rebleeding after endoscopic hemostasis of bleeding peptic ulcers.
The aim of this study was to identify factors associated with rebleeding, including patient factors, after endoscopic hemostasis of bleeding gastroduodenal ulcers and to stratify the risk of rebleeding.
We retrospectively enrolled 587 consecutive patients who were treated for Forrest Ia to IIa bleeding gastroduodenal ulcers with endoscopic hemostasis at three institutions. Risk factors associated with rebleeding were assessed using univariate and multivariate logistic regression analyses. The Rebleeding Nagoya University (Rebleeding-N) scoring system was developed based on the extracted factors. The Rebleeding-N score was internally validated using bootstrap resampling methods.
Sixty-four patients (11%) had rebleeding after hemostasis of gastroduodenal ulcers. Multivariate logistic regression analysis revealed four independent rebleeding risk factors: blood transfusion, albumin <2.5, duodenal ulcer, and diameter of the exposed vessel ≧2 mm. Patients with 4 risk factors in the Rebleeding-N score had a 54% rebleeding rate, and patients with 3 risk factors had 44% and 25% rebleeding rates. In the internal validation, the mean area under the curve of the Rebleeding-N score was 0.830 (95% CI = 0.786-0.870).
Rebleeding after clip hemostasis of bleeding gastroduodenal ulcers was associated with blood transfusion, albumin <2.5, diameter of the exposed vessel ≧2 mm, and duodenal ulcer. The Rebleeding-N score was able to stratify the risk of rebleeding.
胃十二指肠溃疡(GDU)止血后再出血是 GDU 患者死亡相关的指标之一。然而,目前关于内镜止血治疗消化性溃疡出血后再出血风险评分的研究较少。
本研究旨在确定内镜止血治疗胃十二指肠溃疡出血后与再出血相关的因素,并对再出血风险进行分层。
我们回顾性纳入了在三家机构接受内镜止血治疗 Forrest Ia 至 IIa 级胃十二指肠溃疡出血的 587 例连续患者。采用单因素和多因素 logistic 回归分析评估与再出血相关的危险因素。基于提取的因素,制定了再出血名古屋大学(Rebleeding-N)评分系统。采用 bootstrap 重采样方法对内部分值进行验证。
64 例(11%)患者在胃十二指肠溃疡止血后发生再出血。多因素 logistic 回归分析显示,输血、白蛋白<2.5g/dL、十二指肠溃疡和暴露血管直径≥2mm 是 4 个独立的再出血危险因素。Rebleeding-N 评分中 4 个危险因素的患者再出血率为 54%,3 个危险因素的患者再出血率为 44%和 25%。内部验证中,Rebleeding-N 评分的曲线下面积均值为 0.830(95%CI=0.786-0.870)。
夹闭止血治疗胃十二指肠溃疡出血后再出血与输血、白蛋白<2.5g/dL、暴露血管直径≥2mm 和十二指肠溃疡有关。Rebleeding-N 评分能够对再出血风险进行分层。